ABC Labs
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Digital health
- Other products or services
- Other R&D services
- Institute, hospital research
The Artemis Studies, operated by ABC Labs, generate high-resolution, longitudinal data to advance precision health and AI-driven therapeutic discovery and development. Our first application is cardiometabolic disease, focused on individual response to GLP-1 therapies. Built on Sweden’s globally unique registry infrastructure, Artemis links decades of standardized clinical and socioeconomic history with prospective deep phenotyping of consented participants — including standardized genomics, proteomics, biochemical biomarkers, biobanked samples, and structured outcomes from both participants and clinicians. By integrating research and care under documented QA oversight, Artemis provides a consented, regulatory-grade data and a pharma-ready AI training platform for patient stratification, target validation, and treatment response modeling.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}